Greenwich Wealth Management’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
846,201
+27,200
| +3% | +$67.2K | 0.1% | 90 |
|
|
2025
Q1 | $1.63M | Buy |
819,001
+45,000
| +6% | +$89.6K | 0.12% | 91 |
|
|
2024
Q4 | $2.26M | Buy |
774,001
+41,000
| +6% | +$120K | 0.16% | 73 |
|
|
2024
Q3 | $2.84M | Buy |
733,001
+80,000
| +12% | +$310K | 0.19% | 62 |
|
|
2024
Q2 | $3.36M | Buy |
653,001
+75,000
| +13% | +$385K | 0.25% | 49 |
|
|
2024
Q1 | $4.05M | Buy |
578,001
+65,000
| +13% | +$455K | 0.32% | 44 |
|
|
2023
Q4 | $4.55M | Buy |
513,001
+73,980
| +17% | +$655K | 0.45% | 35 |
|
|
2023
Q3 | $4.19M | Buy |
439,021
+231,021
| +111% | +$2.2M | 0.44% | 34 |
|
|
2023
Q2 | $3.05M | Sell |
208,000
-141,000
| -40% | -$2.07M | 0.32% | 52 |
|
|
2023
Q1 | $4.29M | Buy |
+349,000
| New | +$4.29M | 0.47% | 32 |
|